Organisation paid for research Program year 2025 Source: CMS Open Payments

Eastside Research Associates

Neither a doctor nor a teaching hospital

Research payments

$4,223,078

24 payments

Through program year 2025, Eastside Research Associates is reported as receiving $4,223,078 in research payments, across 24 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$188,897	6
2024	Research	$23,511	3
2023	Research	$1,276,719	5
2022	Research	$1,833,977	7
2021	Research	$622,774	2
2020	Research	$277,200	1

Breakdown

Who paid Research payments · program years 2020–2025

Cue Health Inc. $3,929,534 7 payments
Merck Sharp & Dohme Corporation $140,806 5 payments
AstraZeneca Pharmaceuticals LP $80,290 3 payments
Sekisui Diagnostics LLC $55,146 1 payment
Pfizer Inc. $17,303 8 payments

Studies the money was for Research payments · program years 2020–2025

Clinical study for Covid $1,610,401 1 payment
RSV, Covid, Strep $778,593 1 payment
Research Evaluation of the Cue COVID-19 Test $642,429 2 payments
Influenza, Covid, RSV, CT/NG Vaginal Swab $432,647 1 payment
Evaluation of the Cue COVID-19 Test for Home and Over The Counter (OTC) Use for Human Factors/Usability $257,545 1 payment
Clinical study for RSV $207,920 1 payment
A Phase 3, Randomized, Placebo-Controlled, Double Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir MK-4482 in Non-Hospitalized Adults with COVID-19 at High Risk for Disease Progression $89,746 1 payment
Clinical Evaluation of the Sekisui Osom Covid-19 Antigen Home Test $55,146 1 payment
A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia $43,569 1 payment
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event $22,548 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.